Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03656965
What this trial is testing

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Who this might be right for
Drug Use for Unapproved Schedule
Kuwait Cancer Control Center 50
Not applicableUnknownNCT00577057
What this trial is testing

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
Hospital Authority, Hong Kong 798
Not applicableUnknownNCT05595265
What this trial is testing

Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal and Hypopharyngeal Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT03283293
What this trial is testing

Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 112
Testing effectiveness (Phase 2)UnknownNCT05520814
What this trial is testing

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaPD-1 InhibitorsChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 50
Early research (Phase 1)WithdrawnNCT00006106
What this trial is testing

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Lip and Oral Cavity CancerHead and Neck CancerOropharyngeal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04296747
What this trial is testing

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

Who this might be right for
Hypopharyngeal Squamous Cell Carcinoma
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03544099
What this trial is testing

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 2
Not applicableNot Yet RecruitingNCT06407570
What this trial is testing

Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment

Who this might be right for
Oral Cavity CancerDysphagiaQuality of Life
University of Aarhus 100
Testing effectiveness (Phase 2)Study completedNCT03848286
What this trial is testing

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 153
Large-scale testing (Phase 3)Study completedNCT00778908
What this trial is testing

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 120
Not applicableNot Yet RecruitingNCT06947759
What this trial is testing

Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nuclear MedicineOncology
Taichung Veterans General Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05807880
What this trial is testing

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 59
Testing effectiveness (Phase 2)UnknownNCT01516996
What this trial is testing

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Who this might be right for
Oropharyngeal CancerHypopharyngeal Cancer
The Second People's Hospital of Sichuan 80
Not applicableLooking for participantsNCT06174428
What this trial is testing

Validity of Viome's Oral/throat Cancer Test

Who this might be right for
Oral and Throat CancerOropharyngeal Squamous Cell CarcinomaOral Squamous Cell Carcinoma
Viome 1,000
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Early research (Phase 1)Active Not RecruitingNCT02287311
What this trial is testing

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaSevere Chronic Active Epstein Barr Virus+3 more
Baylor College of Medicine 38
Testing effectiveness (Phase 2)UnknownNCT03213587
What this trial is testing

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 51
Large-scale testing (Phase 3)Looking for participantsNCT04136886
What this trial is testing

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 346
Not applicableLooking for participantsNCT06682494
What this trial is testing

Enhancing Oral Cancer Awareness

Who this might be right for
Oral CancerChatbotPatient Education+3 more
Virginia Commonwealth University 60
Next Page